Editorial: Follicle-Stimulating Hormone: Fertility and Beyond
Manuela Simoni +3 more
doaj +1 more source
Background It is challenging to improve the effects of chemotherapy and reduce its adverse impact on the ovaries. Our previous study suggested that the combination of galaxamide could enhance the antitumor effect of cisplatin (CIS) in HeLa cell xenograft
Huan Tao +7 more
doaj +1 more source
Oral follicle-stimulating hormone receptor agonist affects granulosa cells differently than recombinant human FSH. [PDF]
Guner JZ +7 more
europepmc +1 more source
Endocrine Alterations and Signaling Changes Associated with Declining Ovarian Function and Advanced Biological Aging in Follicle-Stimulating Hormone Receptor Haploinsufficient Mice1 [PDF]
Natalia Danilovich +3 more
openalex +1 more source
Polymorphic Mucocutaneous Eruption and Septic Shock in a 75‐Year‐Old Man
JEADV Clinical Practice, EarlyView.
Sweta Subhadarshani +2 more
wiley +1 more source
ABSTRACT Surgical menopause, the removal of both ovaries prior to natural menopause, may impact short‐and long‐term physical and emotional health. An increasingly common cause of surgical menopause is risk‐reducing salpingo‐oophorectomy (RRSO) in those at high inherited risk of ovarian cancer.
Sarah A. L. Price +12 more
wiley +1 more source
Fennel seed (Foeniculum vulgare Mill.) essential oil (FEO), which is rich in the phytoestrogenic compound trans‐anethole, interacts with oestrogen receptors and influences molecular targets within cells and hormonal responses.
Hasan Hüseyin İpçak +3 more
doaj +1 more source
Functional characterization of naturally-occurring constitutively activating/inactivating mutations in equine follicle-stimulating hormone receptor. [PDF]
Byambaragchaa M +4 more
europepmc +1 more source
Purification of a high molecular weight follicle-stimulating hormone receptor-binding inhibitor from human follicular fluid. [PDF]
D. W. Lee +4 more
openalex +1 more source
Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel +5 more
wiley +1 more source

